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The gut microbiota influences the development and homeostasis of the mammalian immune system 1-23 3 , can alter immune cell compositions in mice [4] [5] [6] [7] , and is associated with responses to immunotherapy 24 that rely on the activity of peripheral immune cells [8] [9] [10] [11] [12] 
56
To overcome this limitation, we here quantified the associations between the microbiome and 57 day-by-day changes in peripheral immune cell counts. We investigated the dynamics of immune Table S1 ). The conditioning regimen of 61 radiation and chemotherapy administered to HCT patients is the most severe perturbation to the 62 immune system deliberately performed in humans and thus offers a unique opportunity to investigate 63 dynamic links between gut microbiota and immune system directly in humans. Conditioning depletes 64 circulating white blood cell counts ( Figure 1A ). This can lead to prolonged periods of neutropenia 65 (<500 neutrophils per µl blood) followed by reconstitution after transplanted stem cells have matured 66
sufficiently to release granulocytes from the bone marrow (neutrophil engraftment is defined as 3 67 consecutive days with >500 neutrophils per µl blood, Figure 1A -C). 
77
Figure 1: Immune reconstitution and microbiome dynamics after allogeneic hematopoietic cell transplantation (HCT). A) Three major periods of HCT-immunoablation during chemotherapeutic conditioning before HCT, defined as day 0, post-HCT neutropenia, and reconstitution following neutrophil engraftment-lead to recovery trajectories with large variability between patients. Shown are the average counts (shaded: ±1 standard deviation, σ) of neutrophils, lymphocytes and monocytes per day relative to HCT from patients transplanted between 2003 and 2019 (A), contrasted with two individual patients (B,C) representative of the recovery trajectories for different stem cell graft source; patient 1 who received a peripheral blood stem cell graft, PBSC (shaded region: mean±1 standard deviation of all PBSC patients), and patient 2 who received a graft of umbilical cord blood (shaded region: mean±1 standard deviation of all cord patients). Fecal samples collected during HCT reveal the loss of microbial diversity reported previously 22,23 (D-F) and commensal families (G-I), often replaced by Enterococcaceae domination. J,K). Administration of immunomodulatory medications for the two example patients. quantify the most abundant white blood cells-neutrophils, lymphocytes, monocytes, eosinophils-as 78 well as platelet counts (Figure 1, S1 
81
We have shown previously that HCT patients lose gut microbiota biodiversity and commensal 82 microbial families during their treatment (Figure 1D-I Figure 1D) ; however, microbiota recovery as well as immune reconstitution can vary 
93
To detect a causal link between the microbiota and white blood cell recovery dynamics, we 94 first used data from a recent prospective randomized trial of autologous fecal microbiota 95 transplantation (auto-FMT), which represents a deliberate microbiota manipulation in our patients 22
96
(supplementary methods). Twenty-four patients (Figure 2A , Table S2 ) underwent randomization, 97 resulting in 10 untreated control and 14 treated patients, including patient 3 in Figure S2 . 
181
This finding was observed in all MSK validation data sets (v-score=3, Figure 3D ), as well as among
182
Duke University patients ( Figure S10 ). We furthermore found a G-CSF-associated increase of 43% 
217
We identified microbial genera that consistently associated with increases or decreases in 218 white blood cell counts by first using data from the PBSC patients and then validating the associations 219 in the other cohorts ( Figure 3G ). 
499
FMT treatment as well as patient and timepoint specific random effects. We included random 500 intercept terms for each day i and each patient j, and a fixed effects term for the post-FMT period with 501 associated coefficient "armpost", using the indicator variable "FMT", that is 1 when a patient was 502 from the FMT treated arm of the trial and day was greater than or equal to the day of the FMT 503 procedure. We conducted independent analyses for neutrophil, lymphocyte and monocyte counts. 
508
(D=100, P=24). For convenience of those interested in reanalyzing our data, the part of our data 509 concerning the auto-FMT analysis is available in tidy format (data SD1).
510
Dynamic systems analyses
511
We analyzed factors associated with the observed changes of absolute counts of neutrophils, 512 lymphocytes and monocytes between two days. In the following we describe how chronology of 513 events and biological samples were encoded, and the models used to infer a role of medications,
514
clinical parameters and the microbiome on dynamics of white blood cells.
515
To reveal factors that associate with day-to-day changes in white blood cell counts, we started 516 from a first-order differential equation of white blood cell (W) dynamics:
Where gr represents the intercept, i.e. the base line rate of change during immune reconstitution, and 519 0 are the to-be-estimated coefficients of the predictors 0 , ∈ , of the white blood cell dynamics. Table S1 : Data set summary and patient characteristics. HCT-graft types: TCD: T-cell depleted graft (ex-vivo) 735 by CD34+selection; PBSC: peripheral blood stem cells; BM: bone marrow; cord: umbilical cord blood; 
